Feasibility of Mindfulness Meditation for Adults 65+ With Chronic Low Back Pain

NCT00594243 | Completed Phase 2

• 1 other identifier: 0404190
• Study Type: interventional
• Target: 37
• Locations: 0 countries
• Sites: N/A

Brief Summary

This pilot feasibility experimental study is designed as a randomized wait-list controlled trial of mindfulness meditation for CLBP. A sample of 37 older adults 65 years of age and older will be recruited from a chronic pain clinic, posted flyers, and newspaper advertisements over a 6-month period. Eligibility will be determined by self-report from a checklist reviewed with potential participants over the phone (see appendix for checklist). Pre-intervention study participants will be consented and study measures obtained. After consent and baseline measures, participants will be randomized in blocks of six using a simple randomization process with no stratification using a table of random numbers. After randomization, participants in the intervention group will receive the intervention of eight weekly 90-minute mindfulness meditation sessions. Instead of waiting until all 37 participants have been recruited into the study to do the intervention, the intervention will be done on a rolling basis. This means there will be a minimum of 6 participants per intervention group, with the possibility of three separate intervention groups. If recruitment goes better than expected, then we will offer the intervention to all 18 participants at one time. Controls will not receive any intervention during this time. Immediately post-intervention the measures will be administered again to participants and wait-list controls. Once the intervention is complete and participants and wait-list controls have completed post-intervention measures the mindfulness meditation program will be offered to the wait-list controls. We will try to combine the wait-list controls into one eight-week program. 3 months after the intervention is completed, participants will be asked to complete the measures a third time and any mindfulness meditation they continue to do at home will be quantified. The primary hypotheses are:

1. 1.We expect to be able to recruit 37 eligible individuals with CLBP into the study within a six-month period.
2. 2.We expect participants randomized to the mindfulness meditation intervention to meet an adherence standard of attending 75% of the 8 weekly 90-minute sessions.
3. 3.We expect mindfulness meditation will result in a moderate effect size difference (0.5) between the intervention participants and wait-list control participants on outcome measures of pain, mood, physical function, attention, and QOL.

Conditions

Chronic Low Back Pain

Study Arms (2)

Intervention

EXPERIMENTAL

8-week mindfulness based stress reduction program

Behavioral: Mindfulness based stress reduction program

Wait-list control

ACTIVE COMPARATOR

Wait-list received no intervention during the time the treatment group received the 8-week program

Other: Wait-list control

Interventions

Mindfulness based stress reduction program BEHAVIORAL

8-week mindfulness based stress reduction program

Intervention

Wait-list control OTHER

No treatment given.

Wait-list control

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• All participants will be included if they are:
• years of age or older,
• have intact cognition (Mini-Mental Status Exam (MMSE) \>23),
• CLBP, defined as moderate pain occurring daily or almost every day for at least the previous three months, and
• speak English.

You may not qualify if:

• They will be excluded if they:
• have previously participated in a mindfulness meditation program, and
• have serious underlying illness (like malignancy, infection, unexplained fever, weight loss or recent trauma) causing their pain.

Sponsors & Collaborators

• University of Pittsburgh: lead

Study Officials

• Natalia E Morone, MD, MSc

  University of Pittsburgh

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: January 3, 2008
• First Posted: January 15, 2008
• Study Start: May 1, 2004
• Primary Completion: June 1, 2005
• Study Completion: June 1, 2005
• Last Updated: January 15, 2008

Record last verified: 2008-01